Coverage
-
October 05, 2015
A California federal judge on Monday granted Allergan Inc.'s motion for summary judgment in a $600 million breach-of-contract lawsuit over Botox, holding that the pharmaceutical giant does not have to pay Miotox certain royalties under the terms of a license agreement.
3 other articles on this case.
View all »